During the past decade, Berzelius Clinical Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Berzelius Clinical Research Center" are "Post-surgery Adhesion Formation" (1 trials) and "Tobacco Dependence" (1 trials). Many other conditions were trialed in "Berzelius Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Berzelius Clinical Research Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nicorette® (Nicotine Gum)" (1 trials), "Nicotine" (1 trials), "PXL01" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Berzelius Clinical Research Center" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Berzelius Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Berzelius Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Berzelius Clinical Research Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".